TSC2 and tuberous sclerosis: These results are in keeping with previously published cohorts of TSC patients showing a high level of TSC1 or TSC2 pathogenic variant mosaicism in individuals with a definite or suspected clinical diagnosis of TSC, in particular for TSC2 variants, which account for 92% of mosaic patients [63].